MedTrace Logo

Prediction of BK Virus Reactivation in Kidney Transplant Recipient

NCT06219616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-12-31

No results posted yet for this study

Summary

There has been no effective predicting tool to accurately predict BKV reactivation after kidney transplantation. The aim is to elucidate the use of flow cytometric analysis for both intracellular cytokines and surface activation markers for BKV-specific T cell response in kidney transplant recipients.

Conditions

  • Kidney Transplant Infection
  • BK Virus Infection
  • BK Virus Nephropathy

Interventions

DIAGNOSTIC_TEST

BKV immune monitoring

Blood will be drawn and investigated for BKV-specific T cell response.

Sponsors & Collaborators

  • King Chulalongkorn Memorial Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-03-30
Completion
2025-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06219616 on ClinicalTrials.gov